Status:
COMPLETED
Africa COVID-19 Vaccine Hesitancy
Lead Sponsor:
Bernhard Nocht Institute for Tropical Medicine
Collaborating Sponsors:
Institut de Recherche en Sciences de la Sante, Burkina Faso
University of Bamako
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Vaccine hesitancy is defined by the WHO's Strategic Advisory Group of Experts on Immunization as a 'delay in acceptance or refusal of vaccination despite availability of vaccination services'. This va...
Detailed Description
Coronavirus disease 2019 (COVID-19) was declared a Public Health Emergency of International Concern by the World Health Organization (WHO) in March 2020. Although African countries seem to have weathe...
Eligibility Criteria
Inclusion
- General population
- Be at least 18 years of age, be willing and able to provide written informed consent AND
- Health professionals
- To be health professionals working in health care institutions at all levels of care for the Ministry of Health (MoH)
- freely consent to participate in the study
Exclusion
- All minors (\<18)
- All individuals who do not meet the inclusion criteria listed above and those who are not willing to give written informed consent for participation in this research
- In Senegal
- All those already vaccinated or being offered a vaccination for COVID-19 and refused and/or delayed the vaccination
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2021
Estimated Enrollment :
4977 Patients enrolled
Trial Details
Trial ID
NCT04912284
Start Date
May 5 2021
End Date
June 6 2021
Last Update
June 21 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Henri Gautier Ouedragogo
Ouagadougou, Burkina Faso, 7192
2
Alpha Mahmoud Barry
Conakry, Guinea
3
Seydou Doumbia
Bamako, Mali
4
Sylvain Faye
Dakar, Senegal